A study highlighting statistical gaffes in scientific literature has brought renewed calls for vigilance among mathematically challenged researchers and journal editors.
■

David Cyranoski, Tokyo
Bioethicists are pushing for an investigation into the cloning work of a South Korean research team -but are having no luck in finding someone to lead it.
Woo Suk Hwang from Seoul National University and colleagues cloned a human somatic cell, creating an embryo that they used to establish a stem-cell line. It was a huge leap in a field full of medical promise and a major boost for Korean science.
But ethical questions have been raised, particularly about how egg donors were recruited for the experiment and whether they included junior members of the laboratory (see Nature 429, 3; 2004) .
Hwang denies that any members of his laboratory were donors and he is backed up by the Institutional Review Board (IRB) of Hanyang University Hospital in Seoul, which originally approved the experiment.
But critics question whether the board has been sufficiently rigorous.At its annual meeting in Seoul on 22 May, the Korean Bioethics Association called on Hwang and the review board to answer questions concerning the recruitment of donors and funding sources. "We request the institutes involved and the participants to present clear explanations regarding the following queries about therapeutic human embryonic cloning research," reads the statement they issued.
The questions, posted on the association's homepage and picked up by major South Korean newspapers, include: "Did the Hanyang University Hospital's IRB perform a continuing review on this research project in order to monitor its ethics?" Some bioethicists accuse the board of not including the non-researchers required by guidelines from the Korea Food and Drug Administration. Institutional review boards are obliged to include "more than one attorney or religious representative, not from the fields of medicine, dentistry, oriental medicine, pharmacy or nursing sciences". Hanyang's consisted of 12 doctors, a pharmacologist, a nurse and a theologian.
The bioethics association wants the case pursued by the National Human Rights Commission, an independent investigative body funded by the government. The commission established a bioethics task force two months ago, but senior commissioner Kyung Seo Park says it was set up to implement rules that come into force next year, not to investigate specific research projects.
"There are no provisions to deal with special cases like Professor Hwang's," Park says. He admits that last month a member of the task force asked the Hanyang review board for documents about the research, and that the board said it was not possible to provide them. But he adds, "The task force does not have any kind of binding power so I told them to stop."Park says the commission may still take up an investigation later.
The situation worries Young Mo Koo, a medical ethicist at the University of Ulsan College of Medicine and member of the bioethics association. The Korea Food and Drug Administration oversees commercial projects, but no one regulates basic research involving human samples, says Koo. "It's a grey area," he adds. "There is a serious need for an investigation."
US plans extensive cut to nuclear weapons stockpile
Washington The US government has announced plans for a significant cut in its stockpile of nuclear weapons between now and the end of 2012.
The plan is outlined in a report sent to Congress on 1 June by the National Nuclear Security Administration, which oversees the nation's nuclear stockpile. The report's details are classified, but Linton Brooks, the agency's administrator, says that the stockpile will be cut "almost in half". Currently, the United States is thought to have about 10,000 weapons.
The move has been welcomed by many. But Ivan Oelrich, who directs the Federation of American Scientist's Strategic Security Project, says it does not go far enough."The US still has approximately ten times the number of warheads it needs," he says.
Sandia boss knew I was innocent, says worker
San Diego Sandia National Laboratories is being sued by an employee who claims she was made a scapegoat for security lapses, and that her career and reputation have been ruined in the process.
The New Mexico nuclear weapons lab came under congressional scrutiny in early 2003 after whistle-blowers reported problems with security, such as napping guards and disappearing master keys. An external review committee claimed that Patricia Gingrich contributed to one such lapse -by helping to destroy evidence of an inappropriate romantic liaison. Gingrich says she was later demoted to a job with an $11,000 drop in salary. Gingrich's lawsuit, filed on 19 May, claims that lab president Paul Robinson knew the review's accusations to be false, but reprimanded her publicly in order to persuade Congress that steps were being taken to improve security. The lab has declined to comment on the case.
Correction
A News item in the 3 June issue of Nature (429, 490; 2004) erroneously states that Hanyang University Hospital's Institutional Review Board (IRB) was in violation of Korean Food and Drug Administration guidelines. The article says that the guidelines require IRBs to include more than one layperson. In fact they only require one, which this IRB had appointed. The error in the text was made by a Seoul-based translation company that Nature paid to translate the document. Nature asked the translator to verify the passage prior to publication, but the mistake was overlooked. We apologize for the error. s
Paris In a country where wine is drunk like water, the government is contemplating reclassifying the drink as a 'natural food' instead of alcohol. French winemakers say sales of their national drink have been falling for years, thanks in part to a strict 1991 law on alcohol advertising and anti-drinking campaigns run by the government. They describe the situation as a 'crisis' and say that wine, as an important part of France's culture and history, ought to be given a helping hand.
Their complaints appear to have had an effect. Later this month, Prime Minister Jean-Pierre Raffarin will be presented with draft legislation proposing the reclassification. If passed, this will alleviate the heavy advertising restrictions.
Corking result for French whine
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